These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2910921)

  • 21. Calcium salts of ketoacids as a new treatment strategy for uremic hyperphosphatemia.
    Schaefer K; Erley CM; von Herrath D; Stein G
    Kidney Int Suppl; 1989 Nov; 27():S136-9. PubMed ID: 2636649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between gastric secretion of acid and urinary excretion of calcium after oral supplements of calcium.
    Hunt JN; Johnson C
    Dig Dis Sci; 1983 May; 28(5):417-21. PubMed ID: 6839905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium citrate without aluminum antacids does not cause aluminum retention in patients with functioning kidneys.
    Sakhaee K; Wabner CL; Zerwekh JE; Copley JB; Pak L; Poindexter JR; Pak CY
    Bone Miner; 1993 Jan; 20(1):87-97. PubMed ID: 8453325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium.
    Bo-Linn GW; Davis GR; Buddrus DJ; Morawski SG; Santa Ana C; Fordtran JS
    J Clin Invest; 1984 Mar; 73(3):640-7. PubMed ID: 6707197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of oral bases on aluminum absorption.
    Mauro LS; Kuhl DA; Kirchhoff JR; Mauro VF; Hamilton RW
    Am J Ther; 2001; 8(1):21-5. PubMed ID: 11304654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of calcium supplement preparation containing small amounts of citrate on the absorption of aluminium in normal subjects and in renal failure patients.
    Nestel AW; Meyers AM; Paiker J; Rollin HB
    Nephron; 1994; 68(2):197-201. PubMed ID: 7830856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study.
    Spiegel DM; Farmer B; Smits G; Chonchol M
    J Ren Nutr; 2007 Nov; 17(6):416-22. PubMed ID: 17971314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of calcium gluconate and other calcium supplements as a dietary calcium source on magnesium absorption in rats.
    Chonan O; Takahashi R; Yasui H; Watanuki M
    Int J Vitam Nutr Res; 1997; 67(3):201-6. PubMed ID: 9202982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting.
    Harvey JA; Kenny P; Poindexter J; Pak CY
    J Am Coll Nutr; 1990 Dec; 9(6):583-7. PubMed ID: 2273192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphate binders for control of phosphate retention in chronic renal failure.
    Loghman-Adham M
    Pediatr Nephrol; 1999 Oct; 13(8):701-8. PubMed ID: 10502131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function.
    Heinrich T; Heidt H; Hafner V; Schmidt-Gayk H; Jenetzky E; Walter-Sack I; Mikus G; Bommer J
    Nephrol Dial Transplant; 2008 Sep; 23(9):2861-7. PubMed ID: 18388122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.
    Moe SM; Radcliffe JS; White KE; Gattone VH; Seifert MF; Chen X; Aldridge B; Chen NX
    J Bone Miner Res; 2011 Nov; 26(11):2672-81. PubMed ID: 21826734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis.
    Slatopolsky E; Weerts C; Lopez-Hilker S; Norwood K; Zink M; Windus D; Delmez J
    N Engl J Med; 1986 Jul; 315(3):157-61. PubMed ID: 3724805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary citric acid enhances absorption of aluminum in antacids.
    Slanina P; Frech W; Ekström LG; Lööf L; Slorach S; Cedergren A
    Clin Chem; 1986 Mar; 32(3):539-41. PubMed ID: 3948402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum and lead absorption from dietary sources in women ingesting calcium citrate.
    Nolan CR; DeGoes JJ; Alfrey AC
    South Med J; 1994 Sep; 87(9):894-8. PubMed ID: 8091252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of dietary phosphorus absorption by oral phoshorus binders.
    Graff L; Burnel D
    Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):389-401. PubMed ID: 8746485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of the effects of calcium carbonate and calcium acetate on zinc tolerance test in hemodialysis patients.
    Hwang SJ; Lai YH; Chen HC; Tsai JH
    Am J Kidney Dis; 1992 Jan; 19(1):57-60. PubMed ID: 1739083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium acetate versus calcium carbonate as phosphate binders.
    Ring T
    Nephron; 1993; 63(1):119. PubMed ID: 8446243
    [No Abstract]   [Full Text] [Related]  

  • 39. Control of hyperphosphatemia among patients with ESRD.
    Coladonato JA
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S107-14. PubMed ID: 16251245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients.
    Gallieni M; Cozzolino M; Carpani P; Zoni U; Brancaccio D
    J Nephrol; 2001; 14(3):176-83. PubMed ID: 11439741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.